Emerging Treatment Options for BRAF-mutant Colorectal Cancer – Enduring Webcast

Description

Program Description

---

This webcast is intended to improve care of patients with BRAF-mutant colorectal cancer by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.

Intended Audience

---

This webcast is designed to meet the educational needs of hematologists/oncologists, nurse practitioners, physician assistants, nurses and other health care professionals involved in the treatment of patients with BRAF-mutant colorectal cancer.

Commercial Supporter

---

Supported by Pfizer, Inc.